ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial

NCT00910312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2022-08-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether the Ice-Sense, a novel cryotherapy system (a system that freezes tissues), is safe and effective in the treatment of benign breast tumors such as fibroadenoma.

Conditions

  • Fibroadenoma

Interventions

DEVICE

Ice-Sense

Ice-Sense Cryoprobe

Sponsors & Collaborators

  • IceCure Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Rafi Klein, Dr.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Czechia
  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910312 on ClinicalTrials.gov